Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cruz-Gervis, R. A.
Right arrow Articles by Brigham, K. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cruz-Gervis, R. A.
Right arrow Articles by Brigham, K. L.
(Chest. 2001;120:S9.)
© 2001 American College of Chest Physicians

Regulation of CCAAT/Enhancer-Binding Protein-ß Is Altered in Primary Lung Fibroblasts Obtained From Patients With Idiopathic Pulmonary Fibrosis*

Roberto A. Cruz-Gervis, MD; Arlene A. Stecenko, MD; Timothy S. Blackwell, MD, FCCP; Linda Sealy, PhD; James E. Loyd, MD; Gayle King and Kenneth L. Brigham, MD

* From the Center for Lung Research, Vanderbilt University Medical Center, Nashville, TN.

Correspondence to: Roberto A. Cruz-Gervis, MD, Division of Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, MCN T-1217, Nashville TN 37232-2650

Since BAL fluid interleukin (IL)-6 levels are elevated in multiple chronic inflammatory and fibrotic lung diseases, and since stimulated lung fibroblasts produced large amounts of IL-6 in vitro, these cells may represent a major source of this cytokine. Nuclear factor (NF)-{kappa}B and CCAAT/enhancer-binding protein-ß (C/EBP-ß) are necessary for maximal transcription of IL-6, and the latter has also been shown to induce gene expression of profibrotic factors, namely insulin-like growth factor-1 and collagen I. For those reasons, we asked whether primary lung fibroblasts obtained from lung of patients with idiopathic pulmonary fibrosis (HF-IPF) could have an altered regulation of these transcription factors compared with fibroblasts obtained from normal human lungs (HF-NL).

We stimulated HF-IPF from two different patients and HF-NL from two different control subjects with IL-1ß (10 pg/mL) for 4 h and measured NF-{kappa}B and C/EBP-ß activity by electrophoretic mobility shift assay. We found that NF-{kappa}B activation was increased by IL-1ß and to a similar extent in HF-IPF and HF-NL. C/EBP-ß activity was also increased by IL-1ß, but to a greater degree in HF-IPF. Since C/EBP-ß can regulate its own activity by producing a truncated transcription-repressor isoform (p20), which cannot be differentiated from the full-length transcription-activator isoform (p42) on gel shift, we subjected nuclear extracts from the above experiments to Western blot and used densitometry of the blot to quantify levels of p20 and p42. We found that baseline p42 and p20 production were similar between HF-IPF (4.1 relative densitometric units [RDU] and 1.4 RDU, respectively) and HF-NL (4.2 RDU and 1.8 RDU, respectively). Likewise, IL-1ß-stimulated p42 production was similar in HF-IPF and HF-NL (1.5-fold and 1.2-fold increase over baseline, respectively). In contrast, IL-1ß–induced p20 production was higher in HF-NL compared to HF-IPF (3.0-fold and 1.4-fold increase over baseline, respectively). This resulted in a lower repressor:activator (p20:p42) ratio in HF-IPF (0.38), compared to HF-NL (1.01) [Fig 1 ].



View larger version (23K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1.. Figure 1 . Repressor-activator ratios.

 
We conclude that HF-IPF have an altered C/EBP-ß regulation, which could account for greater capacity to produce proinflammatory and profibrotic cytokines.

Footnotes

Abbreviations: C/EBPß = CCAAT/enhancer-binding protein-ß; HF-NL = fibroblasts obtained from normal human lung; HF-IPF = fibroblasts obtained from lung of patients with idiopathic pulmonary fibrosis; IL = interleukin; NF = nuclear factor; RDU = relative densitometric units





This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cruz-Gervis, R. A.
Right arrow Articles by Brigham, K. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Cruz-Gervis, R. A.
Right arrow Articles by Brigham, K. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS